Estimated reading time 1 min
This post has been archived and may include outdated content

Genome sequencing


Kirsi Suomalainen

Specialist, Communications and Public Affairs


New possibilities for personalised cancer treatment: The most common cancer causing mutations are known, and diagnostic tests and medicines have been developed for them. However, because of the underlying personal gene variations, these medicines are not always effective. In order to identify these personal mutations in cancer patients, we turn to genome sequencing. In this film you can see how the genetic background of a non-responsive leukemia is identified using next-generation sequencing at the Technology Centre of FIMM, the Institute for Molecular Medicine, Finland. In optimal cases, findings from genome sequencing can lead to precise treatment for individual patients.

Read more:

What's this about?